Abstract
Background: Copanlisib is a pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor with predominant PI3K-alpha/delta activity that has demonstrate......
小提示:本篇文献需要登录阅读全文,点击跳转登录

